Megaloblastic Anaemia - haematological findings 2. Megaloblast 3. Sickle Cell Anemia* - etiopathogenesis, laboratory investigations; peripheral blood smear findings 1. Megaloblastic Anaemia** - laboratory investigations; peripheral blood smear**, bone marrow findings** 2. Anaemia******* - define**, classification******, Iron Deficiency Anaemia**** - laboratory diagnosis****; Anemia - morphological classification with examples 3. Hemolytic Anaemia - laboratory investigations* 4. Macrocytic Anaemia - causes all detail answer answer in detail covering imp points as welll in exaam point of view 2mbbs pathology refer robbin harsh moham add diagrams as well cover required points for muhs exam Add histo pathology diagram and gross as well for exam easy to draw diagram

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Reading File
Reading File
Loading Image
Reading File
Searching the Web

sickle cell anemia etiopathogenesis HbS polymerization peripheral smear findings 2nd MBBS pathology

Reading File
Searching the Web

hemolytic anemia laboratory investigations CBC LDH haptoglobin peripheral smear findings pathology exam

Loading Image
Here is the complete, exam-focused answer for your MUHS 2nd MBBS Pathology preparation, covering all the starred topics from your question paper pattern. References are drawn from Goldman-Cecil Medicine, Harrison's Principles of Internal Medicine, and Frameworks for Internal Medicine.

ANAEMIA - Complete MUHS Exam Notes (2nd MBBS Pathology)


1. ANAEMIA - Definition and Classification

Definition (★★)

Anaemia is defined as a reduction in haemoglobin concentration, haematocrit, or red blood cell (RBC) count below the normal range for age and sex, resulting in decreased oxygen-carrying capacity of the blood.
Normal values (remember for exams):
  • Hb: Males >13 g/dL, Females >12 g/dL, Children >11 g/dL
  • PCV/Haematocrit: Males 42-50%, Females 36-45%
  • RBC count: Males 4.5-5.5 million/µL

Morphological Classification of Anaemia (★★★★★★ - Most Important)

Anaemia morphological classification diagram
Based on MCV (Mean Corpuscular Volume) and MCH (Mean Corpuscular Haemoglobin):
TypeMCVMCHExamples
Microcytic Hypochromic<80 fL<27 pgIron deficiency anaemia, Thalassaemia, Sideroblastic anaemia, Anaemia of chronic disease (late), Lead poisoning
Normocytic Normochromic80-100 fL27-32 pgHaemolytic anaemia, Aplastic anaemia, Acute blood loss, Anaemia of chronic disease (early), Renal failure
Macrocytic (Megaloblastic)>100 fLVariableVitamin B12 deficiency, Folate deficiency, Drugs (methotrexate, hydroxyurea)
Macrocytic (Non-megaloblastic)>100 fLVariableLiver disease, Alcoholism, Hypothyroidism, Reticulocytosis
Pathophysiological Classification (also important):
  • Hypoproliferative: Iron deficiency, Anaemia of chronic disease, Bone marrow failure (aplastic anaemia), Renal failure
  • Hyperproliferative (Haemolytic): Haemolytic anaemias (inherited/acquired)
  • Maturation defect: Megaloblastic anaemia (nuclear maturation defect), Thalassaemia (cytoplasmic defect)

2. MEGALOBLASTIC ANAEMIA (★★★★★★)

Definition

Megaloblastic anaemia is defined as anaemia or pancytopenia resulting from failure of DNA synthesis, causing an imbalance of maturation between the nucleus and the cellular cytoplasm. This results in large cells that are subject to maturation arrest and early destruction (ineffective erythropoiesis). (Goldman-Cecil Medicine)

The Megaloblast - What Is It?

A megaloblast is an abnormally large erythroid precursor with:
  • Large cell size (3-4x normal normoblast)
  • Open, lacy (fenestrated) chromatin - nucleus looks immature/"young-looking"
  • Abundant, well-haemoglobinised cytoplasm - cytoplasm matures normally
  • This creates the hallmark: nuclear-cytoplasmic dissociation (cytoplasm mature, nucleus immature)
Megaloblasts arise at all stages: promegaloblast → megaloblast → intermediate megaloblast → late megaloblast (instead of normal pronormoblast → basophilic → polychromatic → orthochromatic normoblast)

Causes of Megaloblastic Anaemia

A. Vitamin B12 (Cobalamin) Deficiency:
  • Pernicious anaemia (autoimmune - anti-parietal cell antibodies, anti-intrinsic factor antibodies) - commonest cause
  • Gastrectomy / gastric bypass (loss of parietal cells → ↓ intrinsic factor)
  • Dietary deficiency (strict vegans/vegetarians)
  • Ileal disease / resection (Crohn's disease, TB of terminal ileum)
  • Fish tapeworm (Diphyllobothrium latum)
  • Bacterial overgrowth (blind loop syndrome)
  • Drugs: metformin, proton pump inhibitors, nitrous oxide
B. Folic Acid Deficiency:
  • Poor dietary intake (alcoholics, elderly, poor diet lacking green leafy vegetables)
  • Increased demand: pregnancy, haemolytic anaemia, rapid cell proliferation
  • Malabsorption: coeliac disease, Crohn's disease, tropical sprue
  • Drugs: methotrexate, trimethoprim, phenytoin, carbamazepine, sulfasalazine
C. Others (Not B12/Folate):
  • Chemotherapy drugs: hydroxyurea, azathioprine, 5-FU
  • Antiretrovirals: zidovudine
  • Hereditary orotic aciduria, Lesch-Nyhan syndrome

Pathogenesis (Mechanism)

B12 Deficiency
    ↓
Methionine synthase blocked
    ↓
Methyl-THF cannot → THF (METHYLFOLATE TRAP)
    ↓
↓ 5,10-methylene THF
    ↓
Thymidylate synthase cannot convert dUMP → dTMP
    ↓
↓ Thymidine → Uracil misincorporated into DNA
    ↓
DNA synthesis impaired → MATURATION ARREST
    ↓
MEGALOBLASTIC CHANGE (all rapidly dividing cells affected)
Key concept: B12 deficiency causes secondary folate deficiency via the "methylfolate trap." Both B12 and folate deficiency produce identical haematological changes - only B12 deficiency causes neurological damage (subacute combined degeneration of the cord).
The cobalamin-B12 absorption diagram (Goldman-Cecil):
Cobalamin absorption pathway

Laboratory Investigations - Megaloblastic Anaemia (★★★★)

A. Complete Blood Count (CBC):
  • Hb: decreased (may be severely low, <7 g/dL)
  • MCV: markedly elevated (often >115 fL, may reach 130-140 fL)
  • MCH: elevated (but MCHC normal - normochromic)
  • WBC: decreased (leucopenia) - due to ineffective granulopoiesis
  • Platelets: decreased (thrombocytopenia)
  • Pancytopenia in severe cases (anaemia + leucopenia + thrombocytopenia)
  • Reticulocyte count: decreased (reticulocytopenia - key differentiator from haemolytic anaemia)
  • RDW: elevated (anisocytosis)
B. Peripheral Blood Smear (PBS) Findings (★★★):
PBS - Megaloblastic anaemia showing macro-ovalocytes, hypersegmented neutrophil, teardrop cells
Fig: PBS in megaloblastic anaemia - arrows = macro-ovalocytes; stars = hypersegmented neutrophil (6-lobed); arrowhead = teardrop RBC
FindingDetails
Macro-ovalocytesLarge oval RBCs (MCV >115 fL); pathognomonic
Hypersegmented neutrophils≥5% neutrophils with ≥5 lobes, or any neutrophil with ≥6 lobes - EARLIEST and most sensitive sign
AnisocytosisVariation in RBC size
PoikilocytosisTeardrop cells (dacrocytes), fragmented cells
Basophilic stipplingOccasionally seen
Howell-Jolly bodiesNuclear remnants in RBCs
Hypersegmented monocytesLess commonly noted
Exam tip: Hypersegmented neutrophils (5-lobed or 6-lobed) are the earliest peripheral smear finding. Macro-ovalocytes are the most characteristic RBC finding.
C. Bone Marrow Aspirate/Biopsy Findings (★★):
Bone marrow findings - megaloblastic precursors and bone marrow biopsy showing hypercellularity
Fig: A = PBS with oval macrocytes and teardrop cells; B = Hypersegmented neutrophil (6 lobes); C = Bone marrow aspirate: megaloblastic erythroid precursors with open lacy chromatin; D = Bone marrow biopsy: hypercellular with erythroid hyperplasia (can mimic acute leukaemia)
FindingDetails
Hypercellular marrowErythroid hyperplasia with ↓ M:E ratio
MegaloblastsLarge erythroblasts with open/lacy chromatin but mature (haemoglobinised) cytoplasm - nuclear-cytoplasmic dissociation
Giant metamyelocytes and band formsGiant, horseshoe-shaped metamyelocytes - pathognomonic of megaloblastic marrow
Ineffective erythropoiesisApoptosis of megaloblasts within the marrow → intramedullary haemolysis
Erythroid dysplasiaNuclear fragments, binucleation
EXAM WARNING: Megaloblastic marrow can be mistaken for acute leukaemia by inexperienced examiners due to large cells with open chromatin. KEY differentiator: MCV is very high and clinical history + serum B12/folate levels resolve the diagnosis.
D. Biochemical Tests:
  • Serum B12: decreased (<200 pg/mL)
  • Serum folate: decreased (in folate deficiency)
  • RBC folate: more reliable than serum folate
  • Serum LDH: markedly elevated (due to intramedullary haemolysis)
  • Indirect bilirubin: elevated (haemolysis)
  • Serum haptoglobin: decreased
  • Serum methylmalonic acid (MMA): elevated in B12 deficiency (most sensitive and specific)
  • Serum homocysteine: elevated in both B12 AND folate deficiency
  • Serum iron: elevated (ineffective erythropoiesis → iron not used → released back)
  • Gastric analysis: achlorhydria in pernicious anaemia
  • Anti-intrinsic factor antibodies: diagnostic of pernicious anaemia
  • Anti-parietal cell antibodies: less specific (positive in 85-90%)
  • Schilling test: historically used to diagnose pernicious anaemia

3. SICKLE CELL ANAEMIA (★)

Etiopathogenesis

Genetics:
  • Autosomal recessive disorder
  • Point mutation in beta-globin gene on chromosome 11
  • GAG → GTG codon change
  • Glutamic acid (position 6) → Valine (hydrophilic → hydrophobic substitution)
  • Results in formation of Haemoglobin S (HbS) instead of HbA
  • Homozygous (HbSS) = Sickle cell disease (severe)
  • Heterozygous (HbAS) = Sickle cell trait (carrier, usually asymptomatic)
Mechanism of Sickling:
Deoxygenation (hypoxia, acidosis, cold, dehydration)
    ↓
HbS polymerises → forms long, rigid "tactoid" fibers/crystals
    ↓
RBC distorts → sickle/crescent shape
    ↓
Two consequences:
[1] HAEMOLYSIS: Sickled cells are rigid, osmotically fragile
    → trapped in spleen and microvessels → destroyed
    → CHRONIC HAEMOLYTIC ANAEMIA (Hb 6-8 g/dL)

[2] VASO-OCCLUSION: Sickled cells occlude microcirculation
    → ischaemia and infarction of organs
    → PAINFUL CRISES (bone, chest, abdomen, CNS)
Factors promoting sickling:
  • Hypoxia (low O2 tension)
  • Acidosis
  • Dehydration (↑ MCHC)
  • Cold/hypothermia
  • Infection
  • High concentration of HbS in cell
  • Absence of HbF (HbF inhibits polymerisation - explains why disease manifests after 6 months when HbF falls)
Protective factors: High HbF concentration (hence neonates are protected; HU induces HbF production)

Pathological Changes in Organs:

  • Spleen: Early - splenomegaly (congestion); Later - autosplenectomy (repeated infarctions → fibrosis/shrinkage → small, fibrotic spleen)
  • Bone marrow: Erythroid hyperplasia → may expand medulla → "hair-on-end" appearance on X-ray
  • Bones: Avascular necrosis (femoral/humeral head), Salmonella osteomyelitis
  • Liver: Hepatomegaly, hepatic sequestration
  • Kidney: Renal papillary necrosis, haematuria
  • CNS: Stroke (children)
  • Lung: Acute chest syndrome
  • Skin: Leg ulcers (chronic)

Laboratory Investigations:

A. CBC:
  • Hb: 6-8 g/dL (chronic haemolytic anaemia)
  • Normocytic normochromic anaemia (MCV normal)
  • Reticulocytosis: 10-25% (compensatory)
  • WBC: elevated (leukocytosis)
  • Platelets: elevated (thrombocytosis)
B. Peripheral Blood Smear (PBS):
FindingSignificance
Sickle cells (drepanocytes)Elongated, crescent-shaped cells; pathognomonic
Target cells (codocytes)Thin RBCs with central density; thin cytoplasm
PolychromasiaReticulocytes (increased red cell production)
Howell-Jolly bodiesDue to functional hyposplenism
Nucleated RBCsIndicate marked erythroid stress
Anisocytosis, poikilocytosisGeneral finding
C. Haemoglobin Electrophoresis:
  • HbSS: HbS 85-95%, HbF 5-15%, NO HbA - DIAGNOSTIC
  • HbAS (trait): HbA ~60%, HbS ~40%
  • Cellulose acetate pH 8.4 or citrate agar pH 6.0
D. Other Tests:
  • Sickling test: RBCs sickle when exposed to reducing agent (sodium metabisulphite) - screening test
  • LDH: elevated
  • Bilirubin (indirect): elevated
  • Haptoglobin: decreased
  • Serum iron: elevated
  • Blood film: as above
E. Solubility Test (Sickledex): HbS is insoluble in deoxygenated buffer = turbid solution (screening)

4. IRON DEFICIENCY ANAEMIA (IDA) - Laboratory Diagnosis (★★★★)

Stages of Iron Deficiency:

StageIron StoresSerum FerritinSerum IronTransferrin/TIBCTransferrin SaturationHbMCV
Stage 1: Iron depletionAbsent↓ (<30 µg/L)NormalNormalNormalNormal
Stage 2: Iron-restricted erythropoiesisAbsent↓↓↑↑↓ (<15%)Normal/borderlineNormal
Stage 3: IDAAbsent↓↓↓↓↑↑↑↓↓ (<15%)↓ (<80 fL)

Laboratory Diagnosis (★★★★)

A. CBC:
  • Hb: decreased
  • MCV: decreased (<80 fL) - microcytic
  • MCH: decreased (<27 pg) - hypochromic
  • MCHC: decreased (<32 g/dL)
  • RDW: elevated (>14%) - anisocytosis (early finding, even before MCV falls)
  • Platelet count: often elevated (thrombocytosis - reactive)
  • Reticulocyte count: low/normal (hypoproliferative)
B. PBS Findings:
FindingDescription
MicrocytesSmall RBCs, MCV <80 fL
HypochromiaPale cells, central pallor >1/3 diameter
Pencil cells (cigar cells)Elongated, thin RBCs - characteristic of IDA
Target cellsOccasionally
Anisocytosis, poikilocytosisGeneral
C. Iron Studies (Most Important Tests):
TestIDANormalAnaemia of Chronic Disease
Serum Ferritin↓ <30 µg/L12-300 µg/LNormal/↑
Serum Iron60-170 µg/dL
TIBC (Transferrin)250-370 µg/dL↓/Normal
Transferrin Saturation↓ <15%20-50%<15%
Serum hepcidinVariable
sTfR (soluble transferrin receptor)-Normal
Exam key: Ferritin <30 µg/L has 92% sensitivity and 98% specificity for IDA. It is the single best non-invasive test for iron stores.
D. Bone Marrow (Gold Standard - rarely done):
  • Absent stainable iron (Perl's Prussian blue stain negative)
  • Erythroid hyperplasia
  • Small, irregular erythroblasts
E. Other:
  • Reticulocyte haemoglobin content (CHr): low
  • % Hypochromic red cells: elevated

5. HAEMOLYTIC ANAEMIA - Laboratory Investigations (★)

Haemolytic anaemia results from premature destruction of RBCs (normal RBC life span 120 days is shortened).

Classified as:

  • Intravascular haemolysis: RBCs destroyed within blood vessels (e.g., ABO incompatibility, PNH, G6PD deficiency)
  • Extravascular haemolysis: RBCs destroyed by macrophages in spleen/liver (e.g., hereditary spherocytosis, autoimmune haemolytic anaemia)

Laboratory Investigations:

A. Evidence of Increased Erythropoiesis (Compensatory):
TestFinding
Reticulocyte count↑↑ (5-20% or more) - most important marker
PBSPolychromasia (blue-staining reticulocytes)
Bone marrowErythroid hyperplasia ↓ M:E ratio
HbDecreased
MCVNormal or ↑ (due to reticulocytosis)
B. Evidence of Increased RBC Destruction:
TestFindingSignificance
Serum LDH↑↑↑ (especially LDH1 and LDH2)Released from lysed RBCs
Indirect (unconjugated) bilirubinHaem catabolism
Serum haptoglobin↓↓ (may be undetectable)Binds free Hb → cleared by liver
Urinary urobilinogen↑↑Excess bilirubin excreted as urobilinogen
Urine haemosiderin+ve in intravascularIron from Hb absorbed by renal tubules
Plasma/serum Hb↑ in intravascularFree Hb in plasma (haemoglobinaemia)
HaemoglobinuriaIn intravascularRed/brown urine
Plasma methemalbumin+ve in intravascularHaem bound to albumin
C. PBS Findings (Depend on Type):
CellDiagnosis Suggested
SpherocytesHereditary spherocytosis, AIHA
Sickle cellsSickle cell anaemia
Schistocytes/helmet cellsMicroangiopathic haemolytic anaemia (TTP, HUS, DIC)
Target cellsThalassaemia, HbC disease
ElliptocytesHereditary elliptocytosis
Bite cells/blister cellsG6PD deficiency
AcanthocytesLiver disease, abetalipoproteinaemia
D. Specific Tests:
TestPurpose
Direct Coombs test (DAT)Detects antibodies/complement on RBCs → +ve in AIHA
Indirect Coombs test (IAT)Detects free antibodies in serum
Osmotic fragility test↑ in hereditary spherocytosis
Ham's test (Acidified serum)+ve in PNH
G6PD assayG6PD deficiency
Haemoglobin electrophoresisSickle cell, thalassaemia
Flow cytometry (CD55/CD59)PNH

6. MACROCYTIC ANAEMIA - Causes in Detail (★★)

Macrocytic anaemia = MCV >100 fL. Divided into MEGALOBLASTIC and NON-MEGALOBLASTIC.

A. Megaloblastic Causes (impaired DNA synthesis):

1. Vitamin B12 (Cobalamin) Deficiency:
  • Pernicious anaemia (autoimmune - most common in adults)
  • Dietary deficiency (strict veganism)
  • Post-gastrectomy (loss of intrinsic factor)
  • Ileal disease (TB, Crohn's, resection, radiation)
  • Bacterial overgrowth / Blind loop syndrome
  • Fish tapeworm (D. latum)
  • Drugs: metformin, PPI, H2 blockers, nitrous oxide
  • Transcobalamin II deficiency (rare)
2. Folic Acid Deficiency:
  • Dietary insufficiency (alcoholics, elderly, poor dietary habits - green leafy vegetables lacking)
  • Increased requirements: pregnancy (neural tube defects if deficient!), haemolytic anaemia, rapid cell turnover
  • Malabsorption: coeliac disease, tropical sprue, Crohn's disease
  • Antifolate drugs: methotrexate, trimethoprim, pyrimethamine, phenytoin, carbamazepine, sulfasalazine
  • Renal dialysis (folate lost)
  • Alcohol (interferes with absorption and increases excretion)
3. Drugs Directly Inhibiting DNA Synthesis:
  • Hydroxyurea (ribonucleotide reductase inhibitor)
  • Azathioprine, 6-mercaptopurine
  • 5-fluorouracil
  • Zidovudine and other antiretrovirals
  • Cytosine arabinoside (Ara-C)
4. Rare Inherited Disorders:
  • Hereditary orotic aciduria
  • Lesch-Nyhan syndrome
  • Thiamine-responsive megaloblastic anaemia (Rogers syndrome)

B. Non-Megaloblastic Causes (NO impaired DNA synthesis - round macrocytes):

CauseMechanism
Liver disease / AlcoholismMost common cause; lipid deposition on RBC membrane → ↑ surface area → round macrocytes; alcohol also directly toxic to marrow
HypothyroidismSlowed erythropoiesis; may also have B12 deficiency (associated autoimmune)
ReticulocytosisReticulocytes are larger than mature RBCs; any condition causing marked reticulocytosis (e.g., haemolysis, haemorrhage) raises MCV
Aplastic anaemiaStress erythropoiesis → larger cells
Myelodysplastic syndromeDysplastic large RBCs (can also show megaloblastic-type changes)
Drugs: hydroxyurea, AZTCan cause macrocytosis without frank megaloblastic change
PregnancyRelative macrocytosis; also at risk for folate deficiency
Chronic lung disease with hypoxaemiaCompensatory erythrocytosis; reticulocytosis
Cold agglutinins/paraproteinaemiaRBC agglutination → falsely elevated MCV on automated count
SplenectomyLoss of "culling" function of spleen → target cells + macrocytes

Distinguishing Megaloblastic vs Non-Megaloblastic Macrocytosis

FeatureMegaloblasticNon-Megaloblastic
RBC shapeOval macrocytes (macro-ovalocytes)Round macrocytes
NeutrophilsHypersegmented (diagnostic)Normal segmentation
Bone marrowMegaloblasts, giant metamyelocytesNormal precursors
B12/FolateLowNormal
LDHMarkedly elevatedMildly elevated
ReticulocytesLowNormal/elevated
DNA synthesisImpairedNormal

QUICK EXAM REVISION BOX

Pathognomonic Features to Remember:

ConditionHallmark Finding
Megaloblastic anaemiaHypersegmented neutrophils + macro-ovalocytes (PBS); Giant metamyelocytes (BM)
Sickle cell anaemiaSickle cells + HbSS on electrophoresis
IDAPencil cells + microcytic hypochromic PBS; ↓ ferritin
Haemolytic anaemia↑ LDH + ↓ haptoglobin + reticulocytosis + ↑ indirect bilirubin
Hereditary spherocytosisSpherocytes + ↑ osmotic fragility + +ve family history

Bone Marrow M:E Ratio (Normal = 3:1)

  • ↓ M:E ratio (e.g., 1:3) = Erythroid hyperplasia → megaloblastic anaemia, haemolytic anaemia, IDA
  • ↑ M:E ratio = Erythroid hypoplasia → aplastic anaemia, pure red cell aplasia

The "Ineffective Erythropoiesis" Concept:

In megaloblastic anaemia: cells made in marrow but die BEFORE reaching circulation → ↑ LDH + ↑ indirect bilirubin BUT low reticulocytes (key differentiator from haemolytic anaemia where reticulocytes are HIGH)

Sources: Goldman-Cecil Medicine International Edition; Harrison's Principles of Internal Medicine 22E (2025, McGraw Hill); Frameworks for Internal Medicine (Wolters Kluwer); Park's Textbook of Preventive and Social Medicine; Robbins Pathologic Basis of Disease (StatPearls supplementary data)
This is a shared conversation. Sign in to Orris to start your own chat.